Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.
about
Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progressionMinimal residual disease in breast cancer: an overview of circulating and disseminated tumour cellsCancer Stem Cell Plasticity Drives Therapeutic ResistanceEpithelial-Mesenchymal Transition and Breast CancerTissue-based identification of stem cells and epithelial-to-mesenchymal transition in breast cancerMicroRNAs and triple negative breast cancerThe Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and TreatmentCancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinomaRegulation of epithelial-mesenchymal transition through SUMOylation of transcription factorsRb suppresses collective invasion, circulation and metastasis of breast cancer cells in CD44-dependent mannerEMT and stem cell-like properties associated with HIF-2α are involved in arsenite-induced transformation of human bronchial epithelial cellsMicroRNAs targeting prostate cancer stem cellsRole of MTA2 in human cancerCritical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancyThe Regulatory Role of MicroRNAs in EMT and CancerThe transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancerElf5 inhibits the epithelial–mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.Accumulation of low-dose BIX01294 promotes metastatic potential of U251 glioblastoma cellsTumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth.The tetraindole SK228 reverses the epithelial-to-mesenchymal transition of breast cancer cells by up-regulating members of the miR-200 family.Pathological features of triple-negative breast cancers that showed progressive disease during neoadjuvant chemotherapyActivation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancerCD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer.Neither epithelial nor mesenchymal circulating tumor cells isolated from breast cancer patients are tumorigenic in NOD-scid Il2rgnull mice.Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypesDormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas.Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomasTargeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerThe epigenetics of epithelial-mesenchymal plasticity in cancer.Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTENThe T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cellsIdentification of PADI2 as a potential breast cancer biomarker and therapeutic target.MicroRNA-200 family modulation in distinct breast cancer phenotypes.A systems view of epithelial-mesenchymal transition signaling states.Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.Dynamic transcription factor networks in epithelial-mesenchymal transition in breast cancer models.
P2860
Q24628819-6C431390-AC84-4A91-83F2-8381B9CCDF7BQ24632821-3707488D-1F90-42B7-8101-7BB8FC60D611Q26748850-15066F34-4D4F-4AD1-8692-F7484CD6FED4Q26770274-20AB9FAC-4F13-4D70-AD3D-55CD0584F730Q26773055-5F5F7CE7-8A6A-4C34-B5E1-EE6010CF398CQ26861556-1B07E856-970A-4C9B-A800-8E1553BC3642Q26862716-1CC6138B-CAD3-4163-9EC3-DE545D7FAC24Q26865458-E2683258-7367-4793-BFBD-7889AA1151B2Q26998068-4B68CD57-A40F-4D54-AAFC-09F4B5C3E325Q27010433-64619D04-D822-4F44-9F55-06B2C1543E3AQ27301808-3EEBFB66-0CD6-4B91-BCCC-6284EFD2C4C5Q27302204-AD45AC93-06F9-4E68-8DB7-9A505CB75257Q28081039-8E876077-0AC4-4A6D-BD3F-EA36E13D287AQ28251565-EF75B8C6-D463-4A55-BBDC-68AC1DCB3A10Q28276295-34D006E2-A8DD-4A7D-B021-12C341BCAA42Q28391426-AB6AD8D5-5BE2-4F51-964A-7A89A7CFDE5FQ28743642-A66C3A82-57D1-452F-A880-EF9FD13BA5A5Q29042375-A9739738-E218-4571-ADCA-91787819202AQ33563809-CDEA4844-8F13-4973-9627-AEC76DE9AC1EQ33597842-35908EAE-DB75-470F-B093-8DB8E28481E7Q33613560-19F104A4-4801-4E7D-97C3-77D6B59126E4Q33681837-047C1088-F2BF-4DA8-B979-2ECFE7CD619AQ33812557-A92CCB0D-5249-44A2-B18A-624CFBED910EQ33873330-6A084E55-F0D2-4387-99F1-A0C88CBD9DD2Q33875120-5FD73C7B-F57A-4C6E-B0FC-5166413F30EFQ33888775-F6FB9607-9594-414F-876E-12836A12D6D3Q33915061-2C5CB4CF-C174-4973-A47E-25E970B7F7CEQ34100400-DA5C494D-3CD5-4339-833E-C026DF23EEDEQ34136905-DDFA9C41-F49B-4F87-B8D2-7AABD8DE4B46Q34197948-B208E966-5B62-47F5-9771-B324568EBC70Q34208986-C372468B-25CF-4EF2-968E-A1E453F385E3Q34295621-591DD2CF-5116-44B8-BF4F-5E122294E004Q34310378-D69C75EC-15A4-4489-A38D-32D45A3CE095Q34326206-723F4AC7-1196-4E15-A9FD-4C3A237273D0Q34397165-E396EA42-3294-4E6F-B57F-95B8660DA1CDQ34461456-2F9A43E6-6F33-4BA7-8E08-108BC63FCEFBQ34462262-9302DC9B-4BDB-40EA-9460-B6382FD0C7EBQ34579646-581A23FF-1415-4316-BC1C-4CAE9E2B5C01Q34628919-FD4F018E-E166-44CD-BB48-56DDD1F69F40Q34672166-C66D7947-D11D-4B31-AC2D-8F00528FA556
P2860
Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epithelial mesenchymal transit ...... r cell lines parallel the CD44
@nl
Epithelial mesenchymal transit ...... notype in human breast cancer.
@en
type
label
Epithelial mesenchymal transit ...... r cell lines parallel the CD44
@nl
Epithelial mesenchymal transit ...... notype in human breast cancer.
@en
prefLabel
Epithelial mesenchymal transit ...... r cell lines parallel the CD44
@nl
Epithelial mesenchymal transit ...... notype in human breast cancer.
@en
P2093
P50
P1476
Epithelial mesenchymal transit ...... notype in human breast cancer.
@en
P2093
Cletus Pinto
Edwin Widodo
Mark Waltham
Richard M Neve
Tony Blick
P2860
P2888
P304
P356
10.1007/S10911-010-9175-Z
P577
2010-06-04T00:00:00Z